I am a health economist specialising in efficiency and equity measurement. I gained a PhD in Health Economics from the University of Sydney and have a Bachelor of Arts from Griffith University. I have held continuous NHMRC funding throughout my career, and currently hold an NHMRC Career Development Fellowship. I have previously held a NHMRC PhD Scholarship and NHMRC Early Career Fellowship, and for my work from these was awarded a Queensland Young Tall Poppies Science Award in 2017. I am currently an Associate Professor of Health Economics within the School of Public Health and Preventative Medicine, Monash University, and have previously held positions at the University of Sydney, within the Charles Perkins Centre and the NHMRC Clinical Trials Centre, and the Australian Institute of Tropical Health and Medicine. 

In recognition of my expertise and standing within the health economics discipline I have been appointed as a member of the Pharmaceutical Benefits Advisory Committee (PBAC) Economics Subcommittee where I provide health economics advice to the PBAC regarding medicines seeking listing on the PBS.

I specialise in efficiency and equity measurement in healthcare using large population-based linked administrative datasets, and economic evaluations alongside clinical trials. Through my research program I partner with health service providers and policymakers to generate real-world evidence that is shaping the current delivery of healthcare and improving outcomes for individuals across Australia.

I have developed Australia’s first simulation models of patient costs and outcomes based on linked administrative data for cancer patients, and mothers and babies that are being utilised to inform the delivery of care across Australia. Along with members of the health economics team at GENImpact Macquarie University, I have also undertaken internationally leading work on microsimulation modeling of the productivity impacts of ill health, which has been presented at the National Press Club, and annual presentations to the Commonwealth Treasury and Department of Health and Ageing. Pfizer UK and Pfizer Canada have also funded replications of this work. My research on out of pocket expenditure in Australia has been directly cited by the Shadow Minister for Health to justify Federal Labor’s campaign to overturn the Medicare rebate freeze, and consistently generated large amounts of media interest with articles in The Guardian, The Age, Courier Mail and Australian Financial Review. She recently appeared on SBS Insights to discuss out of pocket fees. 

My work is funded through NHMRC and MRFF grant schemes or directly by research end-users. I currently hold an NHMRC Career Development Fellowship, and lead the health economics component of multiple NHMRC Project, Partnership and Centre for Research Excellence grants.

I lead a team of health economists who specialise in embedding equity considerations, and patient perspective of healthcare costs and outcomes into economic analyses. I have strong quantitative analysis skills, with extensive experience in modelling health and healthcare costs, linked administrative data analysis, microsimulation modelling using SAS, and conducting economic evaluations alongside clinical trials.